Patient Focused Drug Development - How RDCA-DAP Can Help
Автор: National Organization for Rare Disorders (NORD)
Загружено: 2021-12-08
Просмотров: 417
Patient-Focused Drug Development (PFDD) is a process that provides patients and caregivers impacted by a rare disease the opportunity to share their experience with those directly involved in the drug development process. The Rare Disease Cures Accelerator, a Data Analysis Platform (RDCA-DAP®), a collaboration between the National Organization for Rare Disorders (NORD®), Critical Path Institute (C-Path), and the US Food and Drug Administration (FDA), can strengthen PFDD efforts to support life-saving and life-changing outcomes.
This webinar is intended for patients, caregivers, advocates, students, and those who are interested in learning more about PFDD as well as efforts to accelerate research and drug development in rare diseases, such as the RDCA-DAP.
For more information on RDCA-DAP, visit: www.rarediseases.org/rdca-dap.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
